# Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

> **NCT06798948** · PHASE2 · RECRUITING · sponsor: **Li Lab,MD** · enrollment: 100 (estimated)

## Conditions studied

- Metabolic-associated Fatty Liver Disease (MAFLD)

## Interventions

- **DIETARY_SUPPLEMENT:** Combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabra
- **OTHER:** Placebo maltodextrin

## Key facts

- **NCT ID:** NCT06798948
- **Lead sponsor:** Li Lab,MD
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798948, "Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06798948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*